Examination of human tumors for rhoA mutations.

Article

Examination of human tumors for rhoA mutations.

Oncogene - 1 Jan 1994

Moscow J A, He R, Gnarra J R, Knutsen T, Weng Y, Zhao W P, Whang-Peng J, Linehan W M, Cowan K H

Abstract excerpt

rhoA encodes a ras-related GTP-binding protein that is thought to play a role in cytoskeletal organization. Recent evidence has suggested both that rhoA could act either as a dominant oncogene, since transfection of both normal and activated rho genes confer a transformed phenotype on fibroblast...

Topics

Join the communities discussing this publication.

Neoplasms

GTP-Binding Proteins

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest

Examination of human tumors for rhoA mutations.PMID 8302578Read

The Rho GTPase RhoE is a p53-regulated candidate tumor suppressor in cancer cellsSemantic proximity Read

RHO GTPases in cancer: known facts, open questions, and therapeutic challenges.Semantic proximity Read

Rho GTPases in transformation and metastasis.Semantic proximity Read

Rho proteins and cancer.Semantic proximity Read

RHOA takes the RHOad less traveled to cancer.Semantic proximity Read

Cre-loxP chromosome engineering of a targeted deletion in the mouse corresponding to the 3p21.3 region of homozygous loss in human tumours.Semantic proximity Read

Deregulation of Rho GTPases in cancer.Semantic proximity Read

Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes.Semantic proximity Read